Physicians were presented with a hypothetical pharmaceutical cognitive enhancer that had been approved by the regulatory authorities for use in healthy adults, and was characterized as being safe, effective, and without significant adverse side effects.
The demographic characteristics of participating physicians are presented in Table 2. Results of current practice are shown in Table 3. GPs and Specialists vaccinated their patients against pneumococci in 82,6% and 94,4% of cases respectively.
The physicians were presented a list of 20 factors.
Demographic data for the participating physicians are presented in Table 2.
The reasons given by patients and physicians are presented in Table 3.
In both instances attending physicians were presented with desperate and apparently irretrievable clinical scenarios secondary to poisoning.
Once those were signed, physicians were presented with two of four possible clinical practice scenarios describing conditions commonly managed by family physicians (see Table 1).
Physicians were presented directly (and other staff either directly or indirectly through the physicians) with evidence-based best practices and a facilitative "tool kit".
To elicit discussion about physicians' attitudes about the use of race in treatment decision-making, physicians were presented with a brief clinical vignette describing a hypothetical patient.
